Name Net reduced
positions
Reduced positions Increased positions Return since
31 Mar ‘22
126
9 19 10 3.51%
127
9 29 20 92.6%
128
9 17 8 21.6%
MCRB icon
129
Seres Therapeutics
MCRB
$162M
9 54 45 87%
130
9 23 14 22.4%
131
9 36 27 97.4%
132
9 17 8 8.81%
133
9 21 12 30.9%
134
9 20 11 53.2%
135
9 26 17 87.3%
VRCA icon
136
Verrica Pharmaceuticals
VRCA
$42.3M
9 18 9 94.5%
137
9 10 1 28.6%
138
9 23 14 24.6%
139
9 11 2 94.5%
140
9 13 4 24.5%
141
9 30 21 33.1%
142
9 15 6 5.02%
143
9 11 2 39%
144
8 9 1 69%
145
8 51 43 99.9%
146
8 22 14 88.1%
147
8 11 3 73.4%
148
8 13 5 31.4%
149
8 12 4 17.6%
150
8 24 16 3.76%